Ablexis Announces Licensing of the AlivaMab Mouse Technology to Another Major
Ablexis Appoints Jake Bauer as Senior Director, Corporate Development and Business Operations
Ablexis Appoints Sean Stevens, Ph.D., as Vice President, Research
Ablexis Forms Five-Member Pharmaceutical Consortium to Fund Technology Development
Xconomy San Francisco: "Ablexis Maps Out New Antibody Drug Strategy with $12M from Third Rock, Pfizer"
Ablexis Appoints R. Scott Greer Chairman of the Board and Richard Hoffman Chief Business Officer
Ablexis Secures $12 Million in Series A Funding to Engineer and Commercialize a Next-Generation Platform for Antibody Drug Discovery
Copyright 2012 Ablexis | All Rights Reserved